Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Int J Dent ; 2022: 3215048, 2022.
Article in English | MEDLINE | ID: mdl-35342425

ABSTRACT

Objective: To determine the effects of preirradiation fluoride treatments on the Knoop hardness of dentin. Materials and Methods: Human posterior teeth mounted into acrylic resin molds were polished with silicon carbide (SiC) abrasives and 3-micron diamond paste. The Knoop hardness of dentin was measured with a Leco hardness instrument. The teeth were divided into groups of ten teeth per group as follows: no treatment (control), treatment with silver diamine fluoride (SDF), MI varnish (MI), and cavity shield (CS). The teeth were exposed to 2 Gy of daily radiation for six weeks using an X-Rad 320ix biological irradiator. Hardness was measured weekly, before, during, and after irradiation. The teeth were stored in artificial saliva at 37oC between radiation treatments. Results: In preirradiation dentin, a Knoop hardness value of 58.8 (14.1) KHN was obtained. Treatment with SDF significantly increased KHN before irradiation. Immediately after radiation treatment, hardness was significantly reduced in all experimental groups. Postirradiation fluoride treatments increased the hardness of dentin to varying degrees. Conclusions: Preirradiation fluoride treatment does not provide protection from decreases in the hardness of dentin. Treatment of teeth with fluoride formulations after radiation progressively restores the hardness of dentin to different degrees.

2.
Cancer Res ; 81(18): 4808-4821, 2021 09 15.
Article in English | MEDLINE | ID: mdl-34321243

ABSTRACT

In studies of electron and proton radiotherapy, ultrahigh dose rates of FLASH radiotherapy appear to produce fewer toxicities than standard dose rates while maintaining local tumor control. FLASH-proton radiotherapy (F-PRT) brings the spatial advantages of PRT to FLASH dose rates (>40 Gy/second), making it important to understand if and how F-PRT spares normal tissues while providing antitumor efficacy that is equivalent to standard-proton radiotherapy (S-PRT). Here we studied PRT damage to skin and mesenchymal tissues of muscle and bone and found that F-PRT of the C57BL/6 murine hind leg produced fewer severe toxicities leading to death or requiring euthanasia than S-PRT of the same dose. RNA-seq analyses of murine skin and bone revealed pathways upregulated by S-PRT yet unaltered by F-PRT, such as apoptosis signaling and keratinocyte differentiation in skin, as well as osteoclast differentiation and chondrocyte development in bone. Corroborating these findings, F-PRT reduced skin injury, stem cell depletion, and inflammation, mitigated late effects including lymphedema, and decreased histopathologically detected myofiber atrophy, bone resorption, hair follicle atrophy, and epidermal hyperplasia. F-PRT was equipotent to S-PRT in control of two murine sarcoma models, including at an orthotopic intramuscular site, thereby establishing its relevance to mesenchymal cancers. Finally, S-PRT produced greater increases in TGFß1 in murine skin and the skin of canines enrolled in a phase I study of F-PRT versus S-PRT. Collectively, these data provide novel insights into F-PRT-mediated tissue sparing and support its ongoing investigation in applications that would benefit from this sparing of skin and mesenchymal tissues. SIGNIFICANCE: These findings will spur investigation of FLASH radiotherapy in sarcoma and additional cancers where mesenchymal tissues are at risk, including head and neck cancer, breast cancer, and pelvic malignancies.


Subject(s)
Epithelium , Organ Sparing Treatments , Proton Therapy , Sarcoma/pathology , Sarcoma/radiotherapy , Animals , Bone and Bones/pathology , Bone and Bones/radiation effects , Disease Models, Animal , Dogs , Epithelium/radiation effects , Female , Gene Expression Profiling , Humans , Mice , Morbidity , Muscles/pathology , Muscles/radiation effects , Organ Sparing Treatments/methods , Proton Therapy/adverse effects , Proton Therapy/methods , Radiation Injuries/diagnosis , Radiation Injuries/etiology , Radiotherapy Dosage , Sarcoma/metabolism , Skin/radiation effects , Treatment Outcome
3.
Photochem Photobiol ; 96(3): 684-691, 2020 05.
Article in English | MEDLINE | ID: mdl-32119123

ABSTRACT

Peritoneal carcinomatosis (PC) can occur as an advanced consequence of multiple primary malignancies. Surgical resection, radiation or systemic interventions alone have proven inadequate for this aggressive cancer presentation, since PC still has a poor survival profile. Photodynamic therapy (PDT), in which photosensitive drugs are exposed to light to generate cytotoxic reactive oxygen species, may be an ideal treatment for PC because of its ability to deliver treatment to a depth appropriate for peritoneal surface tumors. Additionally, epidermal growth factor receptor (EGFR) signaling plays a variety of roles in cancer progression and survival as well as PDT-mediated cytotoxicity, so EGFR inhibitors may be valuable in enhancing the therapeutic index of intraperitoneal PDT. This study examines escalating doses of benzoporphyrin derivative (BPD)-mediated intraperitoneal PDT combined with the EGFR-inhibitor cetuximab in a canine model. In the presence or absence of small bowel resection (SBR) and cetuximab, we observed a tolerable safety and toxicity profile related to the light dose received. Additionally, our findings that BPD levels are higher in the small bowel compared with other anatomical regions, and that the risk of anastomotic failure decreases at lower light doses will help to inform the design of similar PC treatments in humans.


Subject(s)
Antineoplastic Agents/administration & dosage , Cetuximab/administration & dosage , Disease Models, Animal , Peritoneal Neoplasms/drug therapy , Photochemotherapy/methods , Photosensitizing Agents/administration & dosage , Porphyrins/administration & dosage , Animals , Antineoplastic Agents/pharmacology , Cetuximab/pharmacology , Dogs , ErbB Receptors/antagonists & inhibitors , Female , Humans , Male
4.
Int J Radiat Oncol Biol Phys ; 106(2): 440-448, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31928642

ABSTRACT

PURPOSE: Recent studies suggest that ultrahigh-dose-rate, "FLASH," electron radiation therapy (RT) decreases normal tissue damage while maintaining tumor response compared with conventional dose rate RT. Here, we describe a novel RT apparatus that delivers FLASH proton RT (PRT) using double scattered protons with computed tomography guidance and provide the first report of proton FLASH RT-mediated normal tissue radioprotection. METHODS AND MATERIALS: Absolute dose was measured at multiple depths in solid water and validated against an absolute integral charge measurement using a Faraday cup. Real-time dose rate was obtained using a NaI detector to measure prompt gamma rays. The effect of FLASH versus standard dose rate PRT on tumors and normal tissues was measured using pancreatic flank tumors (MH641905) derived from the KPC autochthonous PanCa model in syngeneic C57BL/6J mice with analysis of fibrosis and stem cell repopulation in small intestine after abdominal irradiation. RESULTS: The double scattering and collimation apparatus was dosimetrically validated with dose rates of 78 ± 9 Gy per second and 0.9 ± 0.08 Gy per second for the FLASH and standard PRT. Whole abdominal FLASH PRT at 15 Gy significantly reduced the loss of proliferating cells in intestinal crypts compared with standard PRT. Studies with local intestinal irradiation at 18 Gy revealed a reduction to near baseline levels of intestinal fibrosis for FLASH-PRT compared with standard PRT. Despite this difference, FLASH-PRT did not demonstrate tumor radioprotection in MH641905 pancreatic cancer flank tumors after 12 or 18 Gy irradiation. CONCLUSIONS: We have designed and dosimetrically validated a FLASH-PRT system with accurate control of beam flux on a millisecond time scale and online monitoring of the integral and dose delivery time structure. Using this system, we found that FLASH-PRT decreases acute cell loss and late fibrosis after whole-abdomen and focal intestinal RT, whereas tumor growth inhibition is preserved between the 2 modalities.


Subject(s)
Organs at Risk/radiation effects , Proton Therapy/instrumentation , Radiation Injuries, Experimental/prevention & control , Radiation Protection/instrumentation , Radiotherapy, Image-Guided/instrumentation , Abdomen/radiation effects , Animals , Cell Proliferation/radiation effects , Equipment Design/methods , Feasibility Studies , Female , Fibrosis , Gamma Rays , Intestine, Small/pathology , Intestine, Small/radiation effects , Mice , Mice, Inbred C57BL , Organ Sparing Treatments/instrumentation , Organ Sparing Treatments/methods , Organs at Risk/pathology , Pancreatic Neoplasms/radiotherapy , Proton Therapy/methods , Radiation Protection/methods , Radiometry/methods , Radiotherapy, Image-Guided/methods , Scattering, Radiation , Stem Cells/radiation effects , Tomography, X-Ray Computed
5.
Photochem Photobiol ; 95(1): 397-405, 2019 01.
Article in English | MEDLINE | ID: mdl-30499112

ABSTRACT

We have demonstrated that lung-sparing surgery with intraoperative photodynamic therapy (PDT) achieves remarkably extended survival for patients with malignant pleural mesothelioma (MPM). Nevertheless, most patients treated using this approach experience local recurrence, so it is essential to identify ways to enhance tumor response. We previously reported that PDT transiently activates EGFR/STAT3 in lung and ovarian cancer cells and inhibiting EGFR via erlotinib can increase PDT sensitivity. Additionally, we have seen higher EGFR expression associating with worse outcomes after Photofrin-mediated PDT for MPM, and the extensive desmoplastic reaction associated with MPM influences tumor phenotype and therapeutic response. Since extracellular matrix (ECM) proteins accrued during stroma development can alter EGF signaling within tumors, we have characterized novel 3D models of MPM to determine their response to erlotinib combined with Photofrin-PDT. Our MPM cell lines formed a range of acinar phenotypes when grown on ECM gels, recapitulating the locally invasive phenotype of MPM in pleura and endothoracic fascia. Using these models, we confirmed that EGFR inhibition increases PDT cytotoxicity. Together with emerging evidence that EGFR inhibition may improve survival of lung cancer patients through immunologic and direct cell killing mechanisms, these results suggest erlotinib-enhanced PDT may significantly improve outcomes for MPM patients.


Subject(s)
Antineoplastic Agents/therapeutic use , Epidermal Growth Factor/antagonists & inhibitors , Mesothelioma/drug therapy , Photochemotherapy , Cell Line, Tumor , Humans
6.
Life Sci Space Res (Amst) ; 6: 21-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26256624

ABSTRACT

The space environment exposes astronauts to risks of acute and chronic exposure to ionizing radiation. Of particular concern is possible exposure to ionizing radiation from a solar particle event (SPE). During an SPE, magnetic disturbances in specific regions of the Sun result in the release of intense bursts of ionizing radiation, primarily consisting of protons that have a highly variable energy spectrum. Thus, SPE events can lead to significant total body radiation exposures to astronauts in space vehicles and especially while performing extravehicular activities. Simulated energy profiles suggest that SPE radiation exposures are likely to be highest in the skin. In the current report, we have used our established miniature pig model system to evaluate the skin toxicity of simulated SPE radiation exposures that closely resemble the energy and fluence profile of the September, 1989 SPE using either conventional radiation (electrons) or proton simulated SPE radiation. Exposure of animals to electron or proton radiation led to dose-dependent increases in epidermal pigmentation, the presence of necrotic keratinocytes at the dermal-epidermal boundary and pigment incontinence, manifested by the presence of melanophages in the derm is upon histological examination. We also observed epidermal hyperplasia and a reduction in vascular density at 30 days following exposure to electron or proton simulated SPE radiation. These results suggest that the doses of electron or proton simulated SPE radiation results in significant skin toxicity that is quantitatively and qualitatively similar. Radiation-induced skin damage is often one of the first clinical signs of both acute and non-acute radiation injury where infection may occur, if not treated. In this report, histopathology analyses of acute radiation-induced skin injury are discussed.


Subject(s)
Extraterrestrial Environment , Protons/adverse effects , Radiation Exposure/adverse effects , Radiation, Ionizing , Skin/injuries , Skin/radiation effects , Animals , Astronauts , Dose-Response Relationship, Radiation , Environmental Exposure/adverse effects , Models, Animal , Radiation Dosage , Skin Pigmentation/radiation effects , Solar Activity , Solar System , Swine , Swine, Miniature , Whole-Body Irradiation/adverse effects
7.
Article in English | MEDLINE | ID: mdl-23984918

ABSTRACT

The present study examined older and younger adults' ability to use top-down processes to mitigate the effects of display noise during simple feature, visual search. As display noise levels increased, older adults (age 60-74 years, n = 32) exhibited greater top-down search reaction time (RT) benefits (bottom-up minus top-down search RT), compared to younger adults (age 18-27, n = 32). Older adults' ability to mitigate the effects of noise was further assessed with RT variability, as measured by intra-individual standard deviations across trials. Older adults again exhibited larger top-down benefits (i.e., less RT variability) compared to younger adults, and more so when display noise was present vs. absent. These results suggest a sparing of top-down processes with age (Madden, Whiting, Spaniol, & Bucur, 2005; Psychology and Aging, 20, 317), and that top-down processes in older adults enhance search efficiency by optimizing signal-to-noise ratios.


Subject(s)
Discrimination, Psychological , Visual Perception , Adolescent , Adult , Age Factors , Aged , Female , Humans , Male , Middle Aged , Photic Stimulation , Reaction Time , Young Adult
8.
Cancer Biol Ther ; 13(14): 1463-70, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22986230

ABSTRACT

Patients with serosal (pleural or peritoneal) spread of malignancy have few definitive treatment options and consequently have a very poor prognosis. We have previously shown that photodynamic therapy (PDT) can be an effective treatment for these patients, but that the therapeutic index is relatively narrow. Here, we test the hypothesis that EGFR and STAT3 activation increase survival following PDT, and that inhibiting these pathways leads to increased PDT-mediated direct cellular cytotoxicity by examining BPD-PDT in OvCa and NSCLC cells. We found that BPD-mediated PDT stimulated EGFR tyrosine phosphorylation and nuclear translocation, and that EGFR inhibition by erlotinib resulted in reduction of PDT-mediated EGFR activation and nuclear translocation. Nuclear translocation and PDT-mediated activation of EGFR were also observed in response to BPD-mediated PDT in multiple cell lines, including OvCa, NSCLC and head and neck cancer cells, and was observed to occur in response to porfimer sodium-mediated PDT. In addition, we found that PDT stimulates nuclear translocation of STAT3 and STAT3/EGFR association and that inhibiting STAT3 signaling prior to PDT leads to increased PDT cytotoxicity. Finally, we found that inhibition of EGFR signaling leads to increased PDT cytotoxicity through a mechanism that involves increased apoptotic cell death. Taken together, these results demonstrate that PDT stimulates the nuclear accumulation of both EGFR and STAT3 and that targeting these survival pathways is a potentially promising strategy that could be adapted for clinical trials of PDT for patients with serosal spread of malignancy.


Subject(s)
ErbB Receptors/metabolism , Lung Neoplasms/drug therapy , Ovarian Neoplasms/drug therapy , Photochemotherapy , STAT3 Transcription Factor/metabolism , Antineoplastic Agents/pharmacology , Apoptosis , Cell Line, Tumor , Dihematoporphyrin Ether/pharmacology , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/genetics , Erlotinib Hydrochloride , Female , Head and Neck Neoplasms/drug therapy , Humans , Quinazolines/pharmacology , RNA Interference , RNA, Small Interfering , STAT3 Transcription Factor/antagonists & inhibitors , STAT3 Transcription Factor/genetics , Signal Transduction/drug effects
9.
BMC Cancer ; 11: 269, 2011 Jun 24.
Article in English | MEDLINE | ID: mdl-21702963

ABSTRACT

BACKGROUND: Flaxseed (FS) is a dietary supplement known for its antioxidant and anti-inflammatory properties. Radiation exposure of lung tissues occurs either when given therapeutically to treat intrathoracic malignancies or incidentally, such as in the case of exposure from inhaled radioisotopes released after the detonation of a radiological dispersion devise (RDD). Such exposure is associated with pulmonary inflammation, oxidative tissue damage and irreversible lung fibrosis. We previously reported that dietary FS prevents pneumonopathy in a rodent model of thoracic X-ray radiation therapy (XRT). However, flaxseed's therapeutic usefulness in mitigating radiation effects post-exposure has never been evaluated. METHODS: We evaluated the effects of a 10%FS or isocaloric control diet given to mice (C57/BL6) in 2 separate experiments (n = 15-25 mice/group) on 0, 2, 4, 6 weeks post a single dose 13.5 Gy thoracic XRT and compared it to an established radiation-protective diet given preventively, starting at 3 weeks prior to XRT. Lungs were evaluated four months post-XRT for blood oxygenation levels, inflammation and fibrosis. RESULTS: Irradiated mice fed a 0%FS diet had a 4-month survival rate of 40% as compared to 70-88% survival in irradiated FS-fed mouse groups. Additionally, all irradiated FS-fed mice had decreased fibrosis compared to those fed 0%FS. Lung OH-Proline content ranged from 96.5 ± 7.1 to 110.2 ± 7.7 µg/ml (Mean ± SEM) in all irradiated FS-fed mouse groups, as compared to 138 ± 10.8 µg/ml for mice on 0%FS. Concomitantly, bronchoalveolar lavage (BAL) protein and weight loss associated with radiation cachexia was significantly decreased in all FS-fed groups. Inflammatory cell influx to lungs also decreased significantly except when FS diet was delayed by 4 and 6 weeks post XRT. All FS-fed mice (irradiated or not), maintained a higher blood oxygenation level as compared to mice on 0%FS. Similarly, multiplex cytokine analysis in the BAL fluid revealed a significant decrease of specific inflammatory cytokines in FS-fed mice. CONCLUSIONS: Dietary FS given post-XRT mitigates radiation effects by decreasing pulmonary fibrosis, inflammation, cytokine secretion and lung damage while enhancing mouse survival. Dietary supplementation of FS may be a useful adjuvant treatment mitigating adverse effects of radiation in individuals exposed to inhaled radioisotopes or incidental radiation.


Subject(s)
Flax , Lung/radiation effects , Phytotherapy , Plant Preparations/therapeutic use , Radiation Pneumonitis/diet therapy , Radiation-Protective Agents/therapeutic use , Radiotherapy/adverse effects , Seeds , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antioxidants/administration & dosage , Antioxidants/therapeutic use , Bronchoalveolar Lavage Fluid/chemistry , Cachexia/diet therapy , Cachexia/etiology , Cachexia/prevention & control , Cytokines/analysis , Diet , Drug Evaluation, Preclinical , Female , Lignans/blood , Lung/pathology , Mice , Mice, Inbred C57BL , Oxidative Stress , Oxygen/blood , Plant Preparations/administration & dosage , Pulmonary Fibrosis/diet therapy , Pulmonary Fibrosis/etiology , Pulmonary Fibrosis/prevention & control , Radiation Pneumonitis/etiology , Radiation Pneumonitis/prevention & control , Radiation-Protective Agents/administration & dosage , Random Allocation , Weight Loss
11.
ASAIO J ; 51(4): 390-7, 2005.
Article in English | MEDLINE | ID: mdl-16156305

ABSTRACT

A polymethylpentene (PMP) fiber gas exchange device was evaluated in healthy sheep (35-42 kg) to characterize its performance and potential use in clinical extracorporeal life support (ECLS). Five PMP devices (1.3 m2) were compared with five silicone rubber membrane lung (SRML) devices (1.5 m2) that were supported on venovenous ECLS for 72 hours. The two device groups were compared for differences in gas exchange, device pressure gradient, hematology, blood biochemistry, and pathology. The results showed superiority in the PMP devices in both oxygen and CO2 exchange when compared at similar blood flow rates. Platelet consumption and the device pressure gradient were significantly less when using the PMP device. The device pressure gradient across the PMP devices was < 20 mm Hg as compared with > 150 mm Hg for the SRML devices at all blood flow rates. Changes in plasma hemoglobin levels, leukocyte counts, blood chemistry results, and pathologic findings were not significantly different between the two device groups. Plasma leakage or device failure did not occur in any of the test devices. These data support the use of the PMP device for extended circulatory support. Patients may fare better because of improved preservation of platelets, and the low resistance may allow for wider use of centrifugal-style pumps or the use of the device in a pumpless arteriovenous mode.


Subject(s)
Alkenes/chemistry , Extracorporeal Membrane Oxygenation/instrumentation , Oxygenators, Membrane , Animals , Blood Chemical Analysis , Carbon Dioxide/blood , Catheters, Indwelling , Equipment Design , Extracorporeal Membrane Oxygenation/methods , Hemoglobins/analysis , Jugular Veins , Leukocyte Count , Life Support Systems/instrumentation , Oxygen/blood , Pulmonary Gas Exchange , Sheep , Time Factors , Vena Cava, Inferior
SELECTION OF CITATIONS
SEARCH DETAIL
...